Download PDFPDF

Guidelines and adenosine dosing in supraventricular tachycardia
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Pitfalls in the use of Adenosine

    Dear Editor,

    The report by Dixon et al. on the dosing of adenosine is important.[1] That the use of higher starting doses (100 - 200ug/kg) should significantly increase the chance of adenosine terminating the supraventricular tachycardia or demonstrating its mechanism on the first dose was clearly demonstrated in their retrospective review.

    It is worth repeating that the maximum dose for children of 500ug...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    BNF for Children is also incorrect about adenosine dosage

    Dear Editor,

    I am sorry to say that the BNF for Children (, published in October 2005, is also incorrect in its recommendation of starting dosage for use of adenosine in newborns and infants. The BNFC incorrectly recommends starting at 50-100 micrograms/kg and increasing the dose by 50 microgram/kg until a maximum of 300 microgram/kg.


    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Adenosine dosing in Supraventricular Tachycardia - ? Time for change
    • Anjum Gandhi, SpR Paediatric Cardiology
    • Other Contributors:
      • Orhan Uzun

    Dear Editor

    We read with great interest the article by Dixon, Foster, Wyllie and Wren, on the dosing of adenosine in supraventricular tachycardia (SVT). We have recently reviewed cases of SVT presenting to the Children’s Heart unit of Wales with a special focus on the effective dose of Adenosine and have made disturbingly similar observations. Our findings were recently presented in a research society meeting....

    Show More
    Conflict of Interest:
    None declared.